Related Experiment Videos
Risk-benefit profile of intensive blood pressure treatment - Authors' reply
Srinivasan Beddhu1, Tom Greene2, Robert Boucher3
1Medical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA; Division of Nephrology & Hypertension, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
The Lancet. Diabetes & Endocrinology
|July 29, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predictive Value of Urine Tubular Biomarkers on Kidney Outcomes: Observations from EMPA-KIDNEY.
Clinical journal of the American Society of Nephrology : CJASN·2026
Cuffless hemodynamic monitoring with physics-informed machine learning models.
Nature communications·2026
Prebiotic Administration to Chronic Kidney Disease Patients Modifies Their Fecal Microbiome and Host Metabolism.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2025
Effectiveness and efficiency of an add-on active outreach strategy on research enrollments in a drug intervention trial.
Journal of clinical epidemiology·2025
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Clinical journal of the American Society of Nephrology : CJASN·2025
Hypoparathyroidism: translating science from the laboratory to the clinic.
The lancet. Diabetes & endocrinology·2026
Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.
The lancet. Diabetes & endocrinology·2026
From adiposity to multisystem morbidity: the case for weight loss as disease modification.
The lancet. Diabetes & endocrinology·2026
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.
The lancet. Diabetes & endocrinology·2026
Cardiac Resynchronization Therapy Optimization in a Patient with Left Ventricular Non-Compaction Cardiomyopathy and Morbid Obesity.
Current health sciences journal·2026
The Influence of Ageing, Sex and Cause of Death on the Myocardial Tissue Collagen Fibrillary Component Behaviour.
Current health sciences journal·2026
From Data to Decision: Interpretable and Reliable Heart Disease Risk Prediction.
Current health sciences journal·2026
Clinical and Genetic Factors Associated with Multivessel Coronary Artery Disease: A Cross-Sectional Study of CYP2C19 Polymorphisms and Metabolic Comorbidities.
International journal of general medicine·2026